Tokyo Tape
Sign in
← Nihon Parkerizing

Quarterly report · Q1

4095.TEDINET S100OYY1
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥27.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥117.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥28.3bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥2.9bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥4.1bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥4.2bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥17.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.9bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥4.3bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥4.9bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥2.5bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.0bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.0bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥3.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥3.7bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥226.5bnat 2022-06-30Cons.Assets
Total assets¥229.0bnat 2022-03-31Cons.Assets
Total assets¥222.0bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥37.5bnat 2022-06-30Cons.Liabilities
Total liabilities¥41.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥189.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥187.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥180.4bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥72.6bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥75.5bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥21.392022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥76.932021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥25.662021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio70.7%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.0%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio69.5%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥796m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥790m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥17m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥425m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥425m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥369m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue2022-04-01 → 2022-06-30¥3.1bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥3.0bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥56m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentsegment profit2022-04-01 → 2022-06-30−¥194m
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥12.7bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥354m
jpcrp040300-q1r_E00898-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥1.8bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue2022-04-01 → 2022-06-30¥11.1bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue external2022-04-01 → 2022-06-30¥11.1bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥7m
jpcrp040300-q1r_E00898-000Processingreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.6bn
—segment totalrevenue2022-04-01 → 2022-06-30¥26.9bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥26.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥419m
—segment totalsegment profit2022-04-01 → 2022-06-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥27.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥27.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥425m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥3.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥795m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥735m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥59m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30¥19m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥543m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥543m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥385m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue2021-04-01 → 2021-06-30¥4.5bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue external2021-04-01 → 2021-06-30¥4.4bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥99m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentsegment profit2021-04-01 → 2021-06-30¥141m
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue2021-04-01 → 2021-06-30¥12.0bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue external2021-04-01 → 2021-06-30¥11.6bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥376m
jpcrp040300-q1r_E00898-000Medicinereportable segmentsegment profit2021-04-01 → 2021-06-30¥2.3bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue2021-04-01 → 2021-06-30¥11.5bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue external2021-04-01 → 2021-06-30¥11.5bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥8m
jpcrp040300-q1r_E00898-000Processingreportable segmentsegment profit2021-04-01 → 2021-06-30¥2.1bn
—segment totalrevenue2021-04-01 → 2021-06-30¥28.0bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥27.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥483m
—segment totalsegment profit2021-04-01 → 2021-06-30¥4.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥28.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥28.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥543m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥4.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 408
ItemContextValueUnit
Non operating expensesPrior1YTDDuration164000000JPY
Non operating expensesCurrentYTDDuration144000000JPY
Ordinary incomePrior1YTDDuration4932000000JPY
Ordinary incomeCurrentYTDDuration4156000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration5000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration37000000JPY
Gain on sales of investment securities eiPrior1YTDDuration－JPY
Gain on sales of investment securities eiCurrentYTDDuration86000000JPY
Extraordinary incomePrior1YTDDuration5000000JPY
Extraordinary incomeCurrentYTDDuration123000000JPY
Loss on sales and retirement of noncurrent assets elPrior1YTDDuration8000000JPY
Loss on sales and retirement of noncurrent assets elCurrentYTDDuration13000000JPY
Other elPrior1YTDDuration0JPY
Other elCurrentYTDDuration0JPY
Extraordinary lossPrior1YTDDuration8000000JPY
Extraordinary lossCurrentYTDDuration13000000JPY
Income before income taxesPrior1YTDDuration4928000000JPY
Income before income taxesCurrentYTDDuration4266000000JPY
Income taxesPrior1YTDDuration1250000000JPY
Income taxesCurrentYTDDuration1207000000JPY
Profit lossPrior1YTDDuration3677000000JPY
Profit lossCurrentYTDDuration3059000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration659000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration565000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration3017000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration2493000000JPY
Profit lossPrior1YTDDuration3677000000JPY
Profit lossCurrentYTDDuration3059000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-927000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-1286000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration2484000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration3748000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-10000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-37000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration366000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration435000000JPY
Other comprehensive incomePrior1YTDDuration1913000000JPY
Other comprehensive incomeCurrentYTDDuration2860000000JPY
Comprehensive incomePrior1YTDDuration5591000000JPY
Comprehensive incomeCurrentYTDDuration5919000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration4334000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration4151000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration1257000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration1768000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00898-000MedicineReportableSegmentsMember11617000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00898-000EquipmentReportableSegmentsMember4416000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00898-000ProcessingReportableSegmentsMember11485000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember27519000000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember735000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember28255000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass